Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women
NCT07674680Phase 1Recruiting
- Sponsor
- University of Missouri
- Start
- Jul 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Phase 1 trial of vibegron in menopause (2 arms), sponsored by University of Missouri. Primary endpoint: Blood flow. Started Jul 2026; status: recruiting.
02
Drugs
vibegron
03
Conditions
menopause
Beyond the preview
Go deeper on NCT07674680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07674680.